常规早孕期子痫前期联合筛查对小于胎龄儿出生的影响:二次中断时间序列分析
本研究为伦敦某三级医院2017年1月至2019年3月的回顾性队列二次分析,纳入7720名按NICE风险筛查和4841名按FMF多模态筛查的孕妇。中断时间序列分析显示,FMF筛查项目实施21个月后,足月小于胎龄儿(<第10百分位)出生率相对效应降低45.1%(P=0.004),但<第5或<第3百分位无显著降低;两组围产儿死亡及缺氧缺血性脑病无显著差异。
要点
- FMF早孕期联合筛查(含子宫动脉多普勒)实施21个月后,足月SGA<第10百分位出生率相对效应降低45.1%(P=0.004)。
- 足月SGA<第5或<第3百分位出生率无显著相对效应降低。
- FMF筛查组与NICE筛查组的宫内死亡、新生儿死亡及缺氧缺血性脑病发生率无显著差异。
核心结论
- 基于FMF算法的早孕期子痫前期联合筛查配合包含系列超声生长评估和40周起择期分娩的 care package,使足月SGA<第10百分位出生率相对效应显著降低45.1%(P=0.004),但未影响足月SGA<第5或<第3百分位;作者建议需考虑进一步筛查策略以检出并改善SGA<第5百分位病例的结局。
研究设计与样本
- 回顾性队列研究,数据来自伦敦某三级医院2017年1月至2019年3月,为一项早孕期子痫前期筛查项目实施临床有效性研究的二次分析;队列包括7720名按英国国家卫生与临床优化研究所(NICE)风险筛查法筛查的孕妇和4841名按FMF多模态法(结合母体危险因素、血压、妊娠相关血浆蛋白A及子宫动脉多普勒指标)筛查的孕妇;FMF筛查组接受150 mg阿司匹林预防、28周和36周妊娠超声检查及40周计划分娩;采用中断时间序列分析(ITSA)评估结局。
诊断标准与关键数值
- FMF多模态筛查法结合母体危险因素、血压、妊娠相关血浆蛋白A和子宫动脉多普勒指标;SGA按出生体重<第10、<第5、<第3百分位定义;FMF筛查组 care package 包括150 mg阿司匹林预防、28周和36周妊娠超声检查及40周计划分娩。
临床应用与阅片要点
- 作者认为,基于FMF算法的早孕期子痫前期联合筛查配合系列超声生长评估和40周起择期分娩,与足月SGA<第10百分位出生率相对效应降低45.1%相关;作者建议需考虑进一步筛查策略以检出并改善SGA<第5百分位病例的结局。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: To evaluate the impact of a first-trimester combined screening program for pre-eclampsia, based on the Fetal Medicine Foundation (FMF) algorithm, on the rate of small-for-gestational age (SGA) at birth and adverse pregnancy outcome.
METHODS: This was a retrospective cohort study of data obtained from a London tertiary hospital between January 2017 and March 2019. The data were derived from a secondary analysis of the cohort evaluated in a clinical-effectiveness study on the implementation of a first-trimester screening program for pre-eclampsia. The cohort included 7720 women screened according to the UK National Institute for Health and Care Excellence (NICE) risk-based approach and 4841 women screened by the FMF multimodal approach, which combines maternal risk factors, blood pressure, pregnancy-associated plasma protein-A and uterine artery Doppler indices. The care package for the FMF-screened group included 150-mg aspirin prophylaxis, ultrasound scans at 28 and 36 weeks' gestation and scheduled delivery at 40 weeks. Outcome measures included the rates of SGA neonates at birth, admission to the neonatal unit, intrauterine demise, neonatal death and hypoxic-ischemic encephalopathy assessed by interrupted time series analysis (ITSA).
RESULTS: There was no significant difference in the rates of intrauterine demise, neonatal death and hypoxic-ischemic encephalopathy between the FMF-screened and NICE-screened cohorts. ITSA showed a significant reduction in the rate of term SGA birth < 10th percentile at 21 months following implementation of the FMF screening program, with a relative effect reduction of 45.1% (P = 0.004). However, there was no significant relative effect reduction in term SGA birth < 5th or < 3rd percentile.
CONCLUSIONS: First-trimester combined screening for pre-eclampsia based on the FMF algorithm accompanied by a care package including serial ultrasound scans for growth evaluation and elective birth from 40 weeks' gestation resulted in a significant 45% relative effect reduction in term SGA birth < 10th percentile but did not affect term SGA birth < 5th or < 3rd percentile. Further screening strategies to detect and improve the outcome of cases with SGA birth < 5th percentile need to be considered. © 2021 International Society of Ultrasound in Obstetrics and Gynecology.
引用
- Guy GP, Leslie K, Diaz Gomez D, et al. Effect of routine first-trimester combined screening for pre-eclampsia on small-for-gestational-age birth: secondary interrupted time series analysis. Ultrasound Obstet Gynecol. 2022. PMID: 34319638. doi:10.1002/uog.23741
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。